These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6377276)

  • 1. [Clinical evaluation of isosorbitol dinitrate (isosorbide dinitrate) in patients with critical stenosis of coronary arteries].
    Podolec P; Pieniazek P; Badacz L; Tracz W
    Pol Tyg Lek; 1984 Jan; 39(1):13-5. PubMed ID: 6377276
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes of the systolic variations of the left ventricle induced by isosorbitol dinitrate in patients with chronic coronary insufficiency].
    Savioli RM; Del Nero E; Ortiz J; Rangel FA; Barretto AC; Papaléo Netto M; Diament J; Tranchesi J
    Arq Bras Cardiol; 1977 Dec; 30(6):441-4. PubMed ID: 614003
    [No Abstract]   [Full Text] [Related]  

  • 3. [Coronary disease. Clinical experience with a new active substance combination].
    Bouzo H
    Med Welt; 1977 Dec; 28(49):2001-7. PubMed ID: 340839
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value of Iso Mack Retard in the treatment of coronary disease].
    Zminkowska U; Markiewicz M
    Wiad Lek; 1984 Apr; 37(7):496-500. PubMed ID: 6385487
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sorbonit in coronary disease].
    Chojnowski JR; Adamska-Dyniewska H; Florczak H; Chojnowska-Jezierska J; Mockallo T
    Pol Tyg Lek; 1968 May; 23(21):797-9. PubMed ID: 4875472
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of isosorbide dinitrate on neutrophil migration in vivo].
    Wysocki H; Siminiak T; Szczepanik A
    Kardiol Pol; 1989; 32(5):255-8. PubMed ID: 2699625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug.
    Straka RJ; Fish JT; Benson SR; Suh JT
    Pharmacotherapy; 1997; 17(1):126-32. PubMed ID: 9017773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug therapy of coronary heart disease with nitrisken retard].
    Kugler G; Welzel D; Schiess W
    Ther Ggw; 1982 Mar; 121(3):172-87. PubMed ID: 7046127
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness and duration of effect of molsidomine and isosorbide dinitrate in peripheral circulation].
    König FK; Grewe R; Wörz K
    Fortschr Med; 1985 Oct; 103(38):903-6. PubMed ID: 3908257
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term testing of a coronary therapeutic agent under general practice conditions].
    Pascal N
    Med Welt; 1978 Apr; 29(15):635-40. PubMed ID: 417229
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of isosorbide dinitrate on the blood circulation system in patients with ischemic heart disease].
    Gaponenko VA; Santova RA; Chilikina ON; Akhmetova MG; Moskalenko NP; Glezer GA
    Ross Med Zh; 1992; (4):45-7. PubMed ID: 1521022
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ergometric and clinical results of treating coronary disease with isosorbide dinitrate and verapamil].
    Pozenel H
    Med Welt; 1981 Jun; 32(24):988-92. PubMed ID: 7253907
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of slow nitrate by products in heart patients at rest and during cyclo-ergometric tests (author's transl)].
    Boutefeu JM; Righetti A; Rutishauser W
    Ann Cardiol Angeiol (Paris); 1979; 28(2):129-34. PubMed ID: 378089
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of sublingual isosorbide dinitrate on systolic time intervals in normal subjects and those with coronary disease].
    Paterna S; Campisi D; Bivona A; Valenza M; Di Maso N; Alaimo V
    Boll Soc Ital Biol Sper; 1984 Jan; 60(1):29-35. PubMed ID: 6704251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dilating effects of isosorbide dinitrate on diameter of internal thoracic artery graft.
    Koike R; Kimura H
    J Thorac Cardiovasc Surg; 1993 Jun; 105(6):1121-2. PubMed ID: 8501944
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug therapy of coronary heart disease. Comparative effects of nifedipine and isosorbide dinitrate].
    Böhm C; Christl HL; Wald G
    Med Welt; 1982 Sep; 33(36):1242-4. PubMed ID: 7132675
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with isosorbide dinitrate in combination with a beta receptor blockader (Bupranolol)].
    Bernat AC; Riera de Barcia L
    Med Monatsschr; 1976 Oct; 30(10):470-3. PubMed ID: 10516
    [No Abstract]   [Full Text] [Related]  

  • 18. [Isosorbide dinitrate spray: a comparative pharmacodynamic study with a sublingual preparation in patients with chronic cardiac insufficiency].
    Marchionni N; Di Bari M; Ferrucci L; Moschi G; Paoletti M; Salani B; Boncinelli L; Fumagalli S; Schneeweiss A
    Cardiologia; 1988 May; 33(5):505-9. PubMed ID: 3048661
    [No Abstract]   [Full Text] [Related]  

  • 19. [Coronary artery dilatation induced by isosorbide dinitrate injection (author's transl)].
    Lablanche JM; Delforge MR; Timant PY; Thieuleux FA; Bertrand ME
    Nouv Presse Med; 1982 Jun; 11(27):2057-61. PubMed ID: 7110965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of isosorbide dinitrate on the dynamics of the left ventricle and on ischemic electrocardiographic changes during loading with supraventricular stimulation].
    Kozák P; Hes I
    Cas Lek Cesk; 1984 Feb; 123(8):222-4. PubMed ID: 6713473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.